long-term effects of glp-1 receptor agonists The cardiovascular beyond obesity and type 2 diabetes: An anti-atherosclerotic action Novel Insights into the Roles

In 2021, the FDA stamped its approval on high-dose semaglutide under the brand name Wegovy, officially giving doctors a new heavyweight contender for chronic weight management

Its important to emphasize that GLP-1 weight loss drugs are meant to be used in tandem with regular exercise and a healthy diet

This includes hepatic steatosis, where 5% or more hepatocytes have macrovesicular steatosis in the absence of other causes of macrovascular steatosis in individuals who drink little or no alcohol, which is defined as less than 20 g/day for women and less than 30 g/day for men

In: Stoker TB, Greenland JC, editors

Females taking GLP-1 medications had about 35% lower odds of developing breast cancer compared to those who did not use these drugs in the full cohort